Tag: CBD

Using Liposomes to Safely Deliver CBD and Other Pharmaceuticals

The concept of liposomal delivery of drug payloads is not new. For decades, pharmaceutical manufacturers have harnessed this ingenious approach to encapsulating active pharmaceutical ingredients in a ...

FDA Forms Group to Work on Cannabis-Based Products

There is currently a growing interest in the development of therapies derived from cannabis and its components, including cannabidiol (CBD). These products containing cannabis or cannabis derivatives ...

Nemus and Noramco for Manufacturing of CBD Analog

Nemus Bioscience, Inc., focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, announced an agreement with Noramco,...

WHO Plans to Reclassify Cannabis

The World Health Organization (WHO) is planning a global re-classification of the addictive potential of cannabis. As recently reported in the German Medical Journal, the WHO recommends that United Na...

Emerald and Lonza to Develop CBD cGMP-Standard Drug for MS

Patented new chemical entity derived from synthetic cannabidiol will initially target multiple sclerosis and scleroderma. Emerald Health Pharmaceuticals and Lonza have announced an agreement for th...

Instadose Pharma Become Largest Pharmaceutical Producer of CBD Oil

Canadian based company Instadose Pharma Corp. has become the largest cultivator and pharmaceutical producer of CBD oil. Through international partnerships, Instadose's land under cannabis cultivati...

Leader in Cannabinoid-based Drug Development expands Suppliers

Tetra Bio-Pharma Inc. is a leader in cannabinoid-based drug discovery and development confirms its non-exclusive supply agreement for GMP-Grade THC with U.S.-based Rhodes Technologies Inc. The supply ...